Medical University of South Carolina, Hollings Cancer Center — Charleston, South Carolina

Medical University of South Carolina, Hollings Cancer Center is a clinical research site located in Charleston, South Carolina, United States 29425.

Crixeo Health Trust Score: 77/100 (FAIR). This profile has not yet been claimed by the site owner.

Medical University of South Carolina, Hollings Cancer Center has participated in 10 clinical trials with 1 currently active.

Therapeutic areas: Head and Neck Squamous Cell Carcinoma, Squamous Cell Carcinoma of Anal Canal, Colorectal Cancer.

Sponsors: Bicara Therapeutics, Amgen, Pfizer.

Sponsor Feasibility Report

Trust Score: 77/100. Verification status: Crixeo Accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Medical University of South Carolina, Hollings Cancer Center?

Medical University of South Carolina, Hollings Cancer Center has a Crixeo Trust Score of 77/100 (FAIR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Medical University of South Carolina, Hollings Cancer Center conducted?

Medical University of South Carolina, Hollings Cancer Center has 10 clinical trials on record, with 1 currently active. Their work covers Head and Neck Squamous Cell Carcinoma, Squamous Cell Carcinoma of Anal Canal, Colorectal Cancer.

Is Medical University of South Carolina, Hollings Cancer Center accredited by Crixeo Health?

Yes — Medical University of South Carolina, Hollings Cancer Center holds Crixeo Accreditation, the quality standard for clinical research sites. Accredited sites have verified compliance documents, strong patient reviews, and sponsor transparency.

Can I submit a review or complaint about Medical University of South Carolina, Hollings Cancer Center?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.